Article Information
vol. 6 no. 4
Published By
Online ISSN
History
- Received March 18, 2020
- Accepted July 25, 2020
- Published online October 19, 2020.
Copyright & Usage
Copyright ©ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Silke van Koningsbruggen-Rietschel1,
- Jane C. Davies2,
- Tacjana Pressler3,
- Rainald Fischer4,
- Gordon MacGregor5,
- Scott H. Donaldson6,
- Knut Smerud7,
- Nils Meland7,
- Jann Mortensen3,
- Marie Ø. Fosbøl3,
- Damian G. Downey8,
- Astrid H. Myrset9,
- Hugo Flaten9 and
- Philip D. Rye9⇑
- for the SMR-2984 Clinical Trial Study Group
- Philip D. Rye, AlgiPharma AS, Industriveien 33, Sandvika 1337, Norway. E-mail: phil.rye{at}algipharma.com
- 1CF Centre, Faculty of Medicine, University Children's Hospital, Cologne, Germany
- 2Dept of Paediatric Respiratory Medicine, National Heart and Lung Institute, Imperial College London, and Royal Brompton and Harefield NHS Foundation Trust, London, UK
- 3Copenhagen CF Centre, Rigshospitalet, Copenhagen, Denmark
- 4Pneumologische Praxis Pasing, Munich, Germany
- 5Dept of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, UK
- 6Dept of Medicine, UNC School of Medicine, Chapel Hill, NC, USA
- 7SMERUD Medical Research International AS, Oslo, Norway
- 8Centre for Experimental Medicine, Queen's University, Belfast, UK
- 9AlgiPharma AS, Sandvika, Norway
Funding
Cystic Fibrosis Foundation